期刊文献+

VIP在胃腺癌中的表达及临床意义的研究

Vasoactive intestinal peptide expression and its clinical significance in gastric adenocarcinoma
原文传递
导出
摘要 目的研究血管活性肠肽(VIP)在胃腺癌组织和血浆中的表达及其与临床病理因素的关系。方法采用ELISA法检测胃腺癌患者血浆中和正常对照组的VIP水平,RT-PCR方法检测VIP mRNA在胃腺癌组织、其相邻的正常胃腺癌组织及不典型增生胃黏膜的差异表达量,Western Blot法进一步检测胃腺癌组织中VIP蛋白的表达。结果ELISA法检测正常人血浆VIP水平为(5.794±0.014)ng/ml,胃腺癌患者血浆中的VIP水平为(14.437±0.825)ng/ml,两者差异有统计学意义(P〈0.05)。RT-PCR分析胃腺癌组织中VIP mRNA的V/B值明显高于不典型增生胃黏膜及相应的癌旁正常胃黏膜,其V/B值分别为:(1.5261±0.3028)、(0.9334±0.2872)、(0.90514-0.2794),差异有统计学意义(P〈0.01);正常胃窦黏膜与不典型增生胃黏膜中,V/B值的差异无统计学意义(P〉0.05);不同分化程度的胃腺癌组织VIP mRNA表达量的差异有统计学意义(P〈0.05);有淋巴结转移与无淋巴结转移的胃腺癌组织VIP mRNA表达量之间差异亦有统计学意义(P〈0.05)。Western Blot法检测胃腺癌组织VIP蛋白表达量高于正常组织。结论VIP可能参与了胃腺癌的发生。VIP蛋白的过度表达可能与胃腺癌的分化程度、侵袭有关,其表达对判断预后有参考价值。 Objective To investigate the expression of vasoactive intestinal peptide (VIP)in gastric adenocarcinoma, and to evaluate the correlation of VIP level with clinical pathologic parameters. Methods The level of VIP in sera from gastric adenocarcinoma patients and healthy people was investigated by ELISA. Moreover, the differential gene expression between gastric adenocarcinoma, gastric dysplasia, and the corresponding normal gastric mucosa were determined by RT-PCR. Western Blot was also used to measure the expression of VIP in the gastric adenocarcinoma and the normal gastric mucosa. Results The serum level of VIP was (5.794±0.014)ng/ ml in normal control and was (14.437±0.825) ng/ml in gastric adenocarcinoma patients, showing significant difference (P 〈 0.05). Meanwhile, the V/B of gastric adenocarcinoma tissues was greater than that of gastric dysplasia and the corresponding normal gastric mucosa (P〈0.01),the values of V/B were 1.5261± 0.3028, 0.9334±0.2872, and 0.9051±0. 2794, respectively. The values of V/B between normal gastric mucosa and gastric dysplasia were not different significantly (P〉0.05). There were significantly negative correlation between the VIP mRNA expression of the differentiation degree of tumor(P〈0.05). The VIP mRNA expression was higher in gastric adenocarcinoma with lymph node metastasis than that without lymph node matastsis (P〈0.05). The VIP protein expression of the gastric adenocarcinoma tissues was greater than that of normal control. Conclusion This findings provide a direct evidence to support the possibility that VIP play a cofactor role in the pathogenesis of gastric adenocarcinoma.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2008年第6期452-454,共3页 Chinese Journal of Experimental and Clinical Virology
基金 广西科学青年基金(桂科青0447036)
关键词 血管活性肠肽 胃肿瘤 腺癌 病理学 临床 Vasoactive intestinal peptide Stomach neoplasms Adenocarcinoma Pathology, clinical
  • 相关文献

参考文献11

  • 1Snoussi K, Strosberg AD, Ben Ahmed S, et al. Genetic variation in pro-inflammatory cytokines ( interleukin-1 beta, interleukin-1 alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw, 2005,16: 253-260.
  • 2巩兰波,王孟春,陈澄,延锦春,姜若兰.血管活性肠肽对胰腺癌细胞的生长调控[J].世界华人消化杂志,2002,10(5):562-565. 被引量:2
  • 3习明,胡卫列,吕军,张利朝,沈文,王元利.血管活性肠肽和神经肽Y在肾上腺嗜铬细胞瘤中的表达及意义[J].广东医学,2008,29(4):606-607. 被引量:1
  • 4Kim SW, Beauchamp RD, Townsend CM, et al. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells. Surgery, 1991,110:270-276.
  • 5lishi H, Tatsuta M, Baba M, et al. Enhancement by vaso-active intestinal peptide of gastric carcinogenesis induced by N-methy1-N'- nitro-N-nitrosoguanidine in rats. Int J Cancer, 1992,50 : 649-652.
  • 6Li GH, Qian W, Song GQ, et al. Effect of vasoactive intestinal peptide on gastric adenocarcinoma. J Gastroenterol Hepatol, 2007,22 : 1328- 1335.
  • 7Nagakawa O, Murata J, Junicho A, et al. Vasoactive intestinal, peptide (VIP) enhances the cell motility of androgen receptor-transfected DU- 145 prostate cancer cells ( DU- 145/AR). Cancer Lett, 2002, 176 : 93- 99.
  • 8Pence JC, Shorter NA. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res, 1990,50 : 5177-5183.
  • 9黄立锋,姚咏明,盛志勇.树突状细胞与调节性T细胞相互作用研究进展[J].中国病理生理杂志,2008,24(3):610-616. 被引量:16
  • 10王伟,李伟毅.血管活性肠肽的免疫调节作用[J].细胞生物学杂志,2005,27(2):148-152. 被引量:15

二级参考文献50

  • 1De Yun Feng,Hui Zheng,Yi Tan,Rui Xue Cheng Department of Pathology, Hunan Medical University, Changsha 410078, Hunan Province, China New England Biolab, MA, USA.Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance[J].World Journal of Gastroenterology,2001,7(1):33-36. 被引量:76
  • 2Ping Yuan~1 Meng Hong Sun~2 Jin Sheng Zhang~1 Xiong Zeng Zhu~2 Da Ren Shi~2 ~1Department of Pathology,Medical College of Fudan University,~2Department of Pathology,Cancer Hospital/Cancer Institute,Fudan University,Shanghai 200032,ChinaDr.Ping Yuan Studying Province.studying in Medical College of Fudan University,worked in Department of Pathology,Wannan Medical College,having eighteen papers published..APC and K-ras gene mutation in aberrant crypt foci of human colon[J].World Journal of Gastroenterology,2001,7(3):352-356. 被引量:20
  • 3林东军,方志刚,付咏梅,李旭东,黄仁魏.肿瘤抗原联合CD40L致敏树突状细胞诱导CTLs杀伤K562细胞的实验研究[J].中国病理生理杂志,2006,22(9):1751-1755. 被引量:2
  • 4湛海伦,高新,邱剑光,蔡育彬,司徒杰,温星桥.抗原致敏DC与CIK共培养体外抗肾癌效应的研究[J].中国病理生理杂志,2006,22(10):1993-1996. 被引量:9
  • 5Chatila TA. Role of regulatory T cells in human diseases [J]. Allergy Clin Immunol, 2005, 116(5) :949 -959.
  • 6Hock BD, Roberts G, McKenzie JL, et al. Exposure to the electrofusion process can increase the immunogenicity of human cells [J]. Cancer Immunol Immunother, 2005, 54(9) :880 - 890.
  • 7Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25 + CD4 + regulatory T cells [ J ]. Int Immunol, 2005, 16 ( 11 ) :1643 - 1656.
  • 8Fehervari Z, Sakaguchi S. Development and function of CD25^+ CD^4+ regulatory T cells [ J ]. Curr Opin Immunol, 2004, 16(2) :203 - 208.
  • 9Oderup C, Cederbom L, Makowska A, et al. Cytotoxic T lymphocyte antigen -4 - dependent down - modulation of costimulatory molecules on dendritic cells in CD4 + CD25^+ regulatory T - cell - mediated suppression [ J ]. Immunology, 2006, 118(2) : 240 -249.
  • 10Wang Z, Larregina AT, Shufesky W J, et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T - cell deletion and regulatory T cells [J]. Am J Transplant, 2006, 6(6) :1297 -1311.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部